2^nd International Conference on Diabetes and Diabetic Nursing Care September 28-29, 2018 Montreal, Quebec, Canada

Track 1: Diabetes Pathophysiology:

Pathophysiologic modification is a change in task as notable from a structural defect. Diabetes occurs when there is a dis-balance between the demand and manufacture of the hormone insulin. Pathophysiology of diabetes is that in this circumstance the immune system outbreaks and terminates the beta cells of the pancreas which produce insulin. There is lack of beta cell leading to complete insulin deficiency. Whereas in type 2 diabetes there is comparatively lesser deficiency of insulin and not an complete deficiency. This means that the body is incapable to harvest appropriate insulin to overcome the demand. There is Beta cell deficiency coupled with peripheral insulin resistance. Gestational diabetes is the third type of diabetes. It is caused when there are excessive counter-insulin hormones of pregnancy. This paves the way to a state of insulin resistance and high blood sugar in the mother. There may be faulty insulin receptors. These part of diabetes study is covered in ADA meetings and IDF word Diabetes Congress

• Physiology of the endocrine pancreas
• Recent advances in genetics of diabetes
• Pathogenesis of diabetes
• Diabetic myelopathy
• Pathophysiology of hypoglycemia
• Physiology of Diabetes Type 1
• Physiology of Diabetes Type 2
• Alpha and Beta cells

Recommended: Top Diabetes conferences | Endocrinology Conferences | Diabetes Meetings

22^nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 London, UK; 27^th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3^rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland; 3^rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK; 3^rd Health Economics and Patient Safety Conferences April 12-13, 2018 Amsterdam, Netherlands; 13^th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland; 2^nd  Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland; 6^th Medical Informatics and Telemedicine Conferences July 5-6, 2018 Berlin, Germany: Clinical Diabetes, Global Experts Meeting On Diabetes, Hypertension & Metabolic Syndrome July 30-31, 2018 Melbourne, Australia

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

Track 2: Gestational Diabetes:

Gestational diabetes develops during pregnancy (gestation). Like other types of diabetes, gestational diabetes affects how your cells use sugar (glucose). Gestational diabetes causes high blood sugar that can affect your pregnancy and your baby's health.

Any pregnancy complication is concerning, but there's good news. Expectant women can help control gestational diabetes by eating healthy foods, exercising and, if necessary, taking medication. 

Track 3: Diabetes and Dermatology:

Diabetes mellitus is a chronic disorder of metabolic dysregulation involving the abnormal   metabolism of glucose. Diabetes has a significant impact on the healthcare costs of the Western world. Nearly all patients with diabetes eventually develop cutaneous manifestations of the disease. Cutaneous signs of the disease can heighten the suspicions of a physician regarding the diagnosis of diabetes. This article will focus on the clinical features, pathogenesis, and treatment modalities of the various dermatologic manifestations of the disease ranging from the more benign granuloma annulare to the more sinister diabetic ulcer. Cutaneous signs of DM are extremely valuable to the clinician. For example, diabetic bullae, diabetic dermopathy, necrobiosis lipoidica diabeticorum, and the scleroderma-like syndrome of waxy skin with limited joint mobility can alert the physician to the diagnosis of diabetes, eruptive xanthomas reflect the status of glucose and lipid metabolism.

Track 4: Advanced Treatments for Diabetes:

Currently there are plenty number of researches going on in the field of endocrinology-diabetes as it has become a common disorder of endocrine system which is standing at a position causing huge number of deaths and made attain the response on it.The researchers are being held in a direction of early detection to the most effective advanced treatments. Advanced treatments include development of insulin pumps, insulin injections, solid dosage forms, transplantations, surgeries, targeting mst1, artificial pancreas and many more. The advances not only being held to develop new methods but to make the most effective treatment which are affordable even by the ordinary population globally.

• Informatics in the Service of Medicine; Telemedicine, Software and other Technologies
• New Technologies for Treating Obesity and Preventing Related Diabetes
• Adolescent Weight Loss (Bariatric) Surgery

Track 5: Diabetes and Metabolism:

Track 6: Case Study and Research:

The main aim of the diabetes is to detect the overall condition of the disorder, there are many case research studies including animal models and human models. The integrated care for diabetes mellitus in terms of the intermediate clinical and process outcomes, the evidence-based knowledge on its implementation is scarce, and insights generalizable to other settings therefore remain limited.  This study protocol provides a description of the design and methodology of a mixed methods study on the implementation of integrated care for diabetes. The aim of the proposed research is to investigate the mechanisms by which and the context in which integrated care for diabetes has been implemented, which outcomes have been achieved and how the context and mechanisms have affected the outcomes.

Track 7: Diabetes: Nutrition and Myths:

It’s very important for us to get ourselves educated about the nutrition and myths about the diabetes and help out in managing one’s own health. There’s absolutely no doubt that obesity is the main evil contributor for the diabetes and genetics also play an equal role. People even though healthy should get their blood glucose levels checked at the age of 40 and beyond time to time. Early management of obesity and unhealthy eating habits can manage people by not getting exposed to a life time disorder. Avoiding the sugar completely and depending completely on protein food is not correct. The nutrition rich food containing all the essential components can help us stay healthy even before and after get suspected by the disorder.

Track 8: Pediatric Diabetes:

Paediatric diabetes is a condition in children which deals with the endocrine glands disorder, such as variations of physical growth and sexual development in childhood, diabetes and many more. Paediatric Type 1 diabetes is a chronic illness characterized by the body’s inability to produce insulin due to autoimmune destruction of the beta cells in the pancreas. Most paediatric patients with diabetes have type 1 and a lifetime dependence on exogenous insulin. It has been estimated that 20 to 25% of children newly diagnosed with type 1 diabetes are obese.  Children with type 2 diabetes are at a higher risk of cardiovascular disease and micro vascular complications. Diabetes affects about 125,000 youth in USA younger than 19 years. Each year, approximately 13,000 children are diagnosed with diabetes. Until recently, children who diagnosed with diabetes almost exclusively had type 1 diabetes. However, as the prevalence of childhood obesity has tripled in the past 30 years, there has been an accompanying increase in the prevalence of metabolic syndrome, pre-diabetes and type 2 diabetes among children.

Track 9: Diabetes and Immunology:

Diabetes is a disorder which can be caused due to many factors among them immunity is also one of the factors. The destruction of the islet β-cell in T1D is the result of a  complex interplay between multiple players of both the innate and adaptive immune system; immunohistochemical analysis of islet inflammation from pancreata of patients with T1D obtained at autopsy indicate a mononuclear cell infiltrate in islets (termed insulitis) consisting  mainly of macrophages, B cells and T cells. Both CD4+ and CD8+ T cells are required for disease development, by destroying the insulin-producing β cells through the effector functions of Th1 cells and direct killing by cytotoxic T lymphocytes (CTLs). CTLs initiate killing by various mechanisms including the production of inflammatory cytokines such as TNF-a and IFN-g, which act synergistically with IL-1 produced by macrophages in targeting the β-cells; they also directly kill β-cells through the secretion of perforin or by apoptosis by the activation of the Fas-Fas-L pathway.

Track 10: Diabetes and Urology:

Diabetes can cause early onset and increased severity of these problems. Sexual and urologic complications of diabetes occur because of the damage diabetes can cause to blood vessels and nerves. Men may have difficulty with erections or ejaculation. Women may have problems with sexual response and vaginal lubrication. Urinary tract infections and bladder problems occur more often in people with diabetes. People who keep their diabetes under control can lower their risk of the early onset of these sexual and urologic problems. Both men and women with diabetes can develop sexual problems because of damage to nerves and small blood vessels. A number of clinical studies in men and women with diabetes have reported bladder instability or hypersensitivity as the most frequent finding, ranging from 39–61% of subjects.

Track 11: Diabetic Nursing Care:

Nursing management of diabetes includes effective treatment to normalize blood glucose and decrease complications using insulin replacement, balanced diet, and exercise. The nurse should stress the importance of complying with the prescribed treatment program. Tailor your teaching to the patient’s needs, abilities, and developmental stage. Stress the effect of blood glucose control on long-term health.

Track 12: Diabetic Angiopathy:

Diabetic angiopathy is a form of angiopathy associated with diabetes mellitus. While not exclusive, the two most common forms are Diabetic retinopathy and Diabetic nephropathy, whose pathophysiologies are largely identical.

Track 13: Diabetic Ketoacidosis:

Diabetic ketoacidosis is a serious complication of diabetes that occurs when your body produces high levels of blood acids called ketones.

The condition develops when your body can't produce enough insulin. Insulin normally plays a key role in helping sugar (glucose) — a major source of energy for your muscles and other tissues — enter your cells. Without enough insulin, your body begins to break down fat as fuel. This process produces a buildup of acids in the bloodstream called ketones, eventually leading to diabetic ketoacidosis if untreated.

Track 14: Diabetic Nephropathy:

Nephropathy means kidney disease or damage. Diabetic nephropathy is damage to your kidneys caused by diabetes. In severe cases it can lead to kidney failure. But not everyone with diabetes has kidney damage.

The kidneys have many tiny blood vessels that filter waste from your blood. High blood sugar from diabetes can destroy these blood vessels. Over time, the kidney isn't able to do its job as well. Later it may stop working completely. This is called kidney failure.

Certain things make you more likely to get diabetic nephropathy. If you also have high blood pressure or high cholesterol, or if you smoke, your risk is higher. Also, Native Americans, African Americans, and Hispanics (especially Mexican Americans) have a higher risk.

Track 15: Diabetic Osteopathy:

Decreased bone formation is the basic mechanism leading to decreased bone mass. Biochemical markers showed no clear connection with bone density measurement. Insulin and insulin-like growth facotr (IGF) affect bone metabolism. Osteopathy In Patients With Diabetic Disease-Type1: Some clinical studies have shown that patients with diabetic disease-type have a mild decrease in bone mass.

Track 16: Herbal and Alternative Remedies:

Herbal medicine, also called botanical medicine or phytomedicine, refers to using a plant's seeds, berries, roots, leaves, bark, or flowers for medicinal purposes. They are sold as tablets, capsules, powders, teas, extracts, and fresh or dry plants. Many people believe "natural medicine" are always good and safe for them so use herbal medicines to try to maintain or improve their health. The use of herbal remedies is more prevalent in patients with chronic diseases asthma, end-stage renal disease, all endocrine disorders such as diabetes, Osteoporosis, Pancreas Disorders and Adrenal Disorders etc.

• Herbal Drugs Used for the Treatment of Diabetes
• Natural Remedies are used in diabetes cure
• Herbal Medicine for treating diabetes
• Improve glucose tolerance by Herbal Drugs
• Herbal and Natural Supplements for Diabetes
• Importance and Usage of Herbal Medicine
• Other herbal remedies

INTRODUCTION:

With the rapid change of lifestyle and climate, day by day diabetes is getting increased among the peoples. The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030. The prevalence of diabetes is higher in men than women, but there are more women with diabetes than men. The urban population in developing countries is projected to double between 2000 and 2030. Therefore, the purpose of organizing the Diabetes 2018 conference in Montreal is to reunite the people on a global platform and make them raise hands against diabetes.      

About the Conference:

With this enthusiastic support of our Organizing Committee and Editorial Board Member, we are overwhelmed to announce 2nd International Conference on Diabetes and Diabetic Nursing Care (WDC 2018) as a continuum of our previous successful conference. WDC 2018 will be held in Montreal, Canada during September 28-29, 2018. 

This conference includes the renowned scientists, geneticist, microbiologists, doctors, professors, public health planners, physicians, dietitians, pharmacists, students under the research of diabetes, industrial delegates and those using bioinformatics tools for studying under the single roof to discuss and for improving the current therapies, and exploring radical new approaches. The event offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions, workshop, symposium etc.

For more details, please visit: https://diabetes.conferenceseries.com/

Importance & Scope:

WDC 2018 will feature the latest developments in research, diagonosis and prevention and management of diabetes, new insulin analogues and new technologies and devices for diabetic prevention, and for treating obesity and many more. Not only will this innovative conference enhance your practical and theoretical knowledge, it will provide you with the unique opportunity to network with a wide range of professionals in the field of diabetes technologies and treatments.

Societies Associated with Diabetes Research

• International Diabetes Federation- Italy
• Primary Care Diabetes Society
• Australian Diabetes Society
• Emirates Diabetes Society
• Society for Biomedical Diabetes Research
• Immunology of Diabetes Society
• American Association of Diabetes Educators
• American Diabetes Association
• The Asian Association for the Study of Diabetes
• International Association of the Diabetes and Pregnancy Study Groups
• Diabetes Association of Nigeria
• Association of Children's Diabetes Clinicians
• Canadian Diabetes Association
• FAND - Italian Association of Diabetics
• Italian Association for the Defence of the Interests of Diabetics
• Association of Diabetes
• Association National Italian Diabetic Athletes
• Italian Society of Diabetology

Target Audience:

• Endocrinologists
• Doctors
• Physicians
• Researchers
• Scientists
• Diabetes Societies and Associations
• Business Professionals
• Academic Professionals
• Students

The above graph is representing the world diabetes cases by 2035.

Global market and analysis:

Worldwide yearly diabetes-related wellbeing consumption is required to add up to US$678Billions, which is assessed to achieve US$800.8Billions. At present, 12% of today's human services use can be identified with the treatment of individuals with diabetes, and 34% of today's worldwide spending on diabetes can be tended to by diabetes application administrations and items. 

Diabetes therapies hold some of the strongest prospects for pharmaceutical companies. Orally administered anti-diabetic drugs were leading category of drugs in 2014 and showed a rate of growth of at around 6.3% from the total global sales. The total sales for insulin products also increased.

The anti-diabetic products include glucose meters, lancets, test strips, continuous blood glucose meters, insulin, insulin pumps, syringes and other insulin delivery devices and anti-diabetes drugs. The product revenue in bulk comes from the-test strips, insulin and anti-diabetic drugs – which will remain the largest sources of product revenues over the next ten years. 

Anti-diabetic drugs

Global industry, Market, R&D and sales forecasts 2016-2026.

• Anti-diabetic drug revenues to 2026 at overall world level, for 9 therapeutic submarkets and 31 products – assess outlooks for production, marketing and sales.
• Forecasts to 2026 for 11 national markets in the Americas, Europe and Asia – investigate developed and developing countries for demand and revenue potentials.
• Prospects for established competitors, rising companies and new entrants – explore portfolios, opinions, results, strategies, technologies and outlooks for success.
• Review of R&D pipelines – examine progress in research and development, finding technological and medical prospects.
• Analysis of what stimulates and restrains that industry and market – gauge challenges and strengths, helping you compete, gain advantages and succeed.

Top Companies for Diabetes research

• Eli Lilly
• Novo Nordisk
• Merck & Co
• Sanofi
• Takeda
• AstraZeneca
• Johnson &Johnson
• Novartis
• Becton, Dickson and Company
• Business and Economics of Diabetes

The many medical and engineering dimensions to diabetes technology are matched by an equal number of business, economic, insurance coverage and reimbursement problems that must be solved in order for devices manufacturers to develop and provide these technologies for people with diabetes. Good decisions are necessary to develop diabetes technology, but good business decisions are also necessary for this process to succeed.

Top Universities under Diabetic Research

Following are the Top Universities which are dealing with Diabetic Research

• Harvard University (Cambridge, MA, USA),
• Massachusetts Institute of Technology (MIT),
• Columbia University (New York, NY, USA)
• Oxford University (Oxford, UK)
• Yale University (New Haven, CT, USA)
• McMaster University (Hamilton, ON, Canada)
• University of Basel (Basel, Switzerland)
• University of Strasbourg (Strasbourg, France)
• University of Bonn (Bonn, Germany)
• KU Leuven (Catholic University of Louvain)
• Swiss Federal Institute of Technology in Lausanne (Lausanne, Switzerland)
• University of California at Santa Barbara (Santa Barbara, CA, USA)
• Free University of Amsterdam (VU Amsterdam).
• Texas A&M University
• Top Hospitals researching on Diabetes

Following are the Top Hospitals and Research Clinic which are dealing with Diabetic Research

• Mayo clinic (Rochester, MN),
• Massachusetts General Hospital (Boston, MA)
• Cleveland Clinic (Cleveland, OH)
• Johns Hopkins Hospital (Baltimore, MD)
• USCF Medical Centre (San Francisco, CA)
• Bassetlaw Hospital – Workshop, Nottinghamshire (UK)
• Addenbrooke’s Hospital – Cambridge, Barnet General Hospital (UK)
• Cygnet Hospital Beckton (UK)
• Wooridul Spine Hospital-Seoul (South Korea)
• Fortis Memorial Research Institute (India)
• Gleneagles Medical Centre (Tanglin, Singapore)